1. Home
  2. FCAP vs DTIL Comparison

FCAP vs DTIL Comparison

Compare FCAP & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Capital Inc.

FCAP

First Capital Inc.

HOLD

Current Price

$49.35

Market Cap

125.9M

Sector

Finance

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$4.96

Market Cap

123.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCAP
DTIL
Founded
1891
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.9M
123.0M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
FCAP
DTIL
Price
$49.35
$4.96
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$47.00
AVG Volume (30 Days)
3.0K
250.9K
Earning Date
10-24-2025
11-03-2025
Dividend Yield
2.48%
N/A
EPS Growth
25.19
N/A
EPS
4.41
N/A
Revenue
$47,323,000.00
$698,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$135.19
P/E Ratio
$11.34
N/A
Revenue Growth
15.22
N/A
52 Week Low
$28.50
$3.61
52 Week High
$53.85
$8.82

Technical Indicators

Market Signals
Indicator
FCAP
DTIL
Relative Strength Index (RSI) 65.86 37.92
Support Level $48.75 $4.86
Resistance Level $50.00 $5.27
Average True Range (ATR) 0.71 0.43
MACD 0.46 -0.07
Stochastic Oscillator 83.54 15.12

Price Performance

Historical Comparison
FCAP
DTIL

About FCAP First Capital Inc.

First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Share on Social Networks: